These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28290640)

  • 41. Treating opioid dependence.
    Stimmel B
    N Engl J Med; 2001 Feb; 344(7):530; author reply 530-1. PubMed ID: 11221618
    [No Abstract]   [Full Text] [Related]  

  • 42. Medications Development for Treatment of Opioid Use Disorder.
    Townsend EA; Negus SS; Banks ML
    Cold Spring Harb Perspect Med; 2021 Jan; 11(1):. PubMed ID: 31932466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
    Stock C; Shum JH
    J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The alternative therapy.
    Hicks M
    Nurs Stand; 2000 Jul 26-Aug 1; 14(45):18. PubMed ID: 11974198
    [No Abstract]   [Full Text] [Related]  

  • 45. Opioid dependence: rationale for and efficacy of existing and new treatments.
    Fiellin DA; Friedland GH; Gourevitch MN
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid Use in Pregnancy.
    Killion MM
    MCN Am J Matern Child Nurs; 2017; 42(6):360. PubMed ID: 29049062
    [No Abstract]   [Full Text] [Related]  

  • 47. Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.
    Mendelson J; Flower K; Pletcher MJ; Galloway GP
    Exp Clin Psychopharmacol; 2008 Oct; 16(5):435-41. PubMed ID: 18837640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research.
    Clark N; Verster A
    Addiction; 2013 Feb; 108(2):253-5. PubMed ID: 23331880
    [No Abstract]   [Full Text] [Related]  

  • 49. Expanded table: Some drugs for management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
    [No Abstract]   [Full Text] [Related]  

  • 50. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
    Balhara YP
    J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101
    [No Abstract]   [Full Text] [Related]  

  • 51. Availability of Extended-Release Buprenorphine to Treat Opioid Use Disorders Among Medicaid-Covered Patients.
    Shover CL
    Psychiatr Serv; 2021 Feb; 72(2):225-226. PubMed ID: 32907476
    [No Abstract]   [Full Text] [Related]  

  • 52. Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient.
    Book SW; Myrick H; Malcolm R; Strain EC
    Am J Psychiatry; 2007 Jun; 164(6):979. PubMed ID: 17541066
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.
    Webster L; Hjelmström P; Sumner M; Gunderson EW
    J Addict Dis; 2016; 35(4):325-338. PubMed ID: 27267785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of opioid dependence with buprenorphine: current update.
    Soyka M
    Dialogues Clin Neurosci; 2017 Sep; 19(3):299-308. PubMed ID: 29302227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series.
    Ritvo AD; Calcaterra SL; Ritvo JI
    J Addict Med; 2021 May-Jun 01; 15(3):252-254. PubMed ID: 32925232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Buprenorphine clinics: an integrated and multidisciplinary approach to treating opioid dependence.
    Marshalek PJ; Sullivan CR
    W V Med J; 2010; 106(4 Spec No):60-3. PubMed ID: 21932755
    [No Abstract]   [Full Text] [Related]  

  • 58. Buprenorphine-naloxone.
    Hu T; Nijmeh L; Pyle A
    CMAJ; 2018 Nov; 190(47):E1389. PubMed ID: 30478217
    [No Abstract]   [Full Text] [Related]  

  • 59. Post-acute Withdrawal Syndrome.
    Grover C; Sturgill D; Goldman L
    J Addict Med; 2023 Mar-Apr 01; 17(2):219-221. PubMed ID: 36731102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioid Use Disorder and Incarceration - Hope for Ensuring the Continuity of Treatment.
    Binswanger IA
    N Engl J Med; 2019 Mar; 380(13):1193-1195. PubMed ID: 30811904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.